Clinical Trials
25
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (23 trials with phase data)• Click on a phase to view related trials
Application of Time Restriction Feeding in Patients With Type 2 Diabetes Mellitus
- Conditions
- Type 2 Diabetes
- First Posted Date
- 2021-08-20
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- OhioHealth
- Target Recruit Count
- 30
- Registration Number
- NCT05015504
- Locations
- 🇺🇸
OhioHealth Castrop Health Center, Athens, Ohio, United States
Happy, Healthy, Loved: A Mobile-delivered Breastfeeding Self-efficacy Intervention for First Time Parents
- Conditions
- Breast Feeding
- First Posted Date
- 2020-10-08
- Last Posted Date
- 2023-07-14
- Lead Sponsor
- OhioHealth
- Target Recruit Count
- 128
- Registration Number
- NCT04578925
- Locations
- 🇺🇸
OhioHealth, Columbus, Ohio, United States
Postextubation Management in Patients at Risk for Extubation Failure
- Conditions
- Ventilatory Failure
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2022-01-13
- Lead Sponsor
- OhioHealth
- Target Recruit Count
- 6
- Registration Number
- NCT04258020
- Locations
- 🇺🇸
OhioHealth Grant Medical Center, Columbus, Ohio, United States
Safety and Efficacy of the Noxsano Wound Care Bandage
- Conditions
- Diabetic Foot UlcerWound HealPeripheral Artery DiseaseUlcer, LegUlcer FootArterial Insufficiency
- First Posted Date
- 2019-10-10
- Last Posted Date
- 2023-12-11
- Lead Sponsor
- OhioHealth
- Target Recruit Count
- 13
- Registration Number
- NCT04123093
- Locations
- 🇺🇸
OhioHealth, Columbus, Ohio, United States
Comparing Specimen Collection Techniques to Screen for Sexually Transmitted Infections in Pregnant Women: A Pilot Study
- Conditions
- Sexually Transmitted Diseases
- First Posted Date
- 2019-03-15
- Last Posted Date
- 2021-02-05
- Lead Sponsor
- OhioHealth
- Target Recruit Count
- 17
- Registration Number
- NCT03877263
- Locations
- 🇺🇸
OhioHealth Doctors Hospital, Columbus, Ohio, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
News
InspireMD Receives FDA Approval for CGuard Prime Carotid Stent System with Record-Low Stroke Rates
InspireMD's CGuard Prime Carotid Stent System received FDA premarket approval based on the C-GUARDIANS pivotal trial showing the lowest 30-day (0.95%) and 1-year (1.93%) major adverse event rates of any carotid intervention study.
Phase 3 PROSTATE-IQ Trial Launches to Reduce Hormone Therapy Burden in Prostate Cancer Patients
• The phase 3 PROSTATE-IQ trial has enrolled its first patient, evaluating ArteraAI Prostate Test's ability to identify men who can safely reduce or avoid hormone therapy after prostatectomy. • The study will stratify patients with biochemical recurrence into risk groups, with low-risk patients receiving either 6 months of ADT or apalutamide monotherapy, while high-risk patients receive either 24 months of ADT or 6 months of ADT with apalutamide. • Led by Dr. Karen Elizabeth Hoffman from MD Anderson Cancer Center, the trial aims to improve quality of life by minimizing hormone therapy side effects while maintaining treatment efficacy across 11 clinical sites in the US.